A detailed history of Exchange Traded Concepts, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 48,427 shares of NVCR stock, worth $780,158. This represents 0.02% of its overall portfolio holdings.

Number of Shares
48,427
Previous 40,155 20.6%
Holding current value
$780,158
Previous $687,000 10.04%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$15.61 - $23.34 $129,125 - $193,068
8,272 Added 20.6%
48,427 $756,000
Q2 2024

Aug 13, 2024

SELL
$11.83 - $24.05 $222,108 - $451,538
-18,775 Reduced 31.86%
40,155 $687,000
Q1 2024

Apr 15, 2024

SELL
$12.42 - $17.29 $184,176 - $256,393
-14,829 Reduced 20.1%
58,930 $921,000
Q4 2023

Jan 05, 2024

BUY
$11.13 - $15.78 $251,838 - $357,054
22,627 Added 44.25%
73,759 $1.1 Million
Q3 2023

Oct 18, 2023

BUY
$16.15 - $42.35 $553,767 - $1.45 Million
34,289 Added 203.58%
51,132 $825,000
Q2 2023

Jul 20, 2023

SELL
$40.29 - $82.51 $39,605 - $81,107
-983 Reduced 5.51%
16,843 $698,000
Q1 2023

Apr 12, 2023

SELL
$56.44 - $118.81 $16,875 - $35,524
-299 Reduced 1.65%
17,826 $1.07 Million
Q4 2022

Jan 17, 2023

BUY
$63.98 - $85.37 $23,544 - $31,416
368 Added 2.07%
18,125 $1.33 Million
Q3 2022

Oct 07, 2022

SELL
$67.99 - $89.57 $278,011 - $366,251
-4,089 Reduced 18.72%
17,757 $1.35 Million
Q2 2022

Jul 20, 2022

SELL
$56.6 - $89.9 $576,697 - $915,991
-10,189 Reduced 31.81%
21,846 $1.52 Million
Q1 2022

Apr 26, 2022

SELL
$60.15 - $84.52 $169,983 - $238,853
-2,826 Reduced 8.11%
32,035 $2.65 Million
Q4 2021

Jan 13, 2022

BUY
$75.08 - $121.99 $1.58 Million - $2.56 Million
20,985 Added 151.23%
34,861 $2.62 Million
Q3 2021

Oct 18, 2021

BUY
$116.17 - $194.55 $373,486 - $625,478
3,215 Added 30.16%
13,876 $1.61 Million
Q2 2021

Jul 30, 2021

SELL
$130.4 - $225.58 $326,652 - $565,077
-2,505 Reduced 19.03%
10,661 $2.37 Million
Q1 2021

Apr 20, 2021

BUY
$124.11 - $190.17 $724,430 - $1.11 Million
5,837 Added 79.64%
13,166 $1.74 Million
Q4 2020

Jan 19, 2021

SELL
$112.16 - $174.14 $223,983 - $347,757
-1,997 Reduced 21.41%
7,329 $1.27 Million
Q3 2020

Oct 30, 2020

BUY
$58.05 - $111.31 $190,520 - $365,319
3,282 Added 54.3%
9,326 $1.04 Million
Q2 2020

Jul 15, 2020

BUY
$57.2 - $74.41 $249,964 - $325,171
4,370 Added 261.05%
6,044 $358,000
Q1 2020

Apr 14, 2020

BUY
$57.05 - $95.75 $62,926 - $105,612
1,103 Added 193.17%
1,674 $113,000
Q4 2019

Jan 22, 2020

BUY
$68.3 - $93.8 $38,999 - $53,559
571 New
571 $48,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.69B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.